GE Healthcare Announces Strategic Changes to Operations and Leadership Team for Global Growth
TL/DR –
GE HealthCare announced a strategic evolution to its operations and executive leadership to better serve patients and customers globally, enhance execution, accelerate innovation, and create efficiencies. Phil Rackliffe has been appointed President and CEO of Advanced Imaging Solutions (AIS), a new segment that combines Imaging and Advanced Visualization Solutions to create a $14.6 billion segment; Catherine Estrampes has been appointed Chief Commercial and Growth Officer for GE HealthCare and will lead Global Markets, a new region that encompasses every market except for China. These changes are designed to streamline the organization, while expanding the reach of the company’s D3 strategy—integrating smart devices and pharmaceuticals, enabled by AI and cloud across disease states—to help deliver more comprehensive, precision care worldwide.
GE HealthCare Announces Strategic Evolution to Drive Growth
GE HealthCare has unveiled a strategic plan aimed at accelerating growth by enhancing global patient and customer service. This includes operational changes and executive restructuring effective immediately, designed to boost innovation and create efficiencies.
Phil Rackliffe is the new President and CEO of Advanced Imaging Solutions (AIS), a $14.6 billion segment formed by merging Imaging and Advanced Visualization Solutions (AVS). The AIS will foster a connected end-to-end imaging ecosystem for diagnosis, intervention, and follow-up across different disease states. It comprises an AI-enabled portfolio of diverse imaging solutions designed to enhance workflows and facilitate real-time procedural support. The Pharmaceutical Diagnostics (PDx) and Patient Care Solutions (PCS) will operate as separate segments.
Catherine Estrampes is appointed as Chief Commercial and Growth Officer for GE HealthCare, leading Global Markets, excluding China. In this role, she will oversee the company’s commercial operations and facilitate scaling of expertise across markets, thereby bringing a more comprehensive portfolio to global customers.
Both Estrampes and Rackliffe bring decades of experience in medical technology and will work to streamline the organization, expand the company’s D3 strategy, and aid in delivering precision care worldwide. These changes are expected to enhance growth and margin acceleration in 2026 and beyond.
Meanwhile, Roland Rott, former President and CEO of Imaging, is leaving GE HealthCare to pursue new opportunities. He made significant contributions in leading strategic acquisitions such as Caption Health, icometrix, and BK Medical, enhancing GE HealthCare’s ultrasound capabilities.
Elie Chaillot, previously in charge of Europe, the Middle East and Africa, will now focus on high-priority initiatives and special projects for the company.
GE HealthCare will provide updated financial results reflecting the new segment structure in its filings with the U.S. Securities and Exchange Commission for Q2 2026.
New Executives’ Background
Phil Rackliffe joined GE HealthCare in 2022 and has significantly contributed to the company’s growth and innovation. Catherine Estrampes, who joined GE HealthCare in 1990, has held diverse leadership roles, leading to her current appointment as the Chief Commercial and Growth Officer.
—
Read More Health & Wellness News ; US News